Sign In
Buy CTSO
$0.361
+0.0108 (+3.08%)
At Close: Jul 31, 2026
PRINCETON, N.J. and HYDERABAD, India, Nov. 11, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit (IC
Cytosorbents Corporation (CTSO) Q3 2024 Earnings Call Transcript
01:20pm, Saturday, 09'th Nov 2024
Cytosorbents Corporation (NASDAQ:CTSO ) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET Company Participants Adanna Alexander - IR Phillip Chan - CEO & Director Peter Mariani - CFO Confer
CytoSorbents files for FDA De Novo marketing approval of DrugSorb-ATR to reduce the severity of CABG-related bleeding due to the blood thinner ticagrelor
CytoSorbents to Present at the H.C. Wainwright 26ᵗʰ Annual Global Investment Conference
07:00am, Tuesday, 27'th Aug 2024
PRINCETON, N.J., Aug. 27, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery usin
CytoSorbents Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Friday, 16'th Aug 2024
PRINCETON, N.J., Aug. 16, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery usin
Cytosorbents Corporation (CTSO) Q2 2024 Earnings Call Transcript
10:31pm, Tuesday, 13'th Aug 2024
Cytosorbents Corporation (NASDAQ:CTSO ) Q2 2024 Earnings Conference Call August 13, 2024 4:30 PM ET Company Participants Eric Ribner - IR Phillip Chan - CEO Kathleen Bloch - CFO Vincent Capponi - Pres
CytoSorbents Reports Second Quarter 2024 Financial and Operational Results
04:19pm, Tuesday, 13'th Aug 2024
PRINCETON, N.J., Aug. 13, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a pioneer in critical care and cardiac surgery blood purification technologies, today reported unaudited fin
CytoSorbents Appoints Peter J. Mariani Chief Financial Officer
04:18pm, Tuesday, 13'th Aug 2024
PRINCETON, N.J., Aug. 13, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery usin
CytoSorbents to Report Second Quarter 2024 Operating and Financial Results
07:00am, Wednesday, 07'th Aug 2024
PRINCETON, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery usin
CytoSorbents Announces Compliance with Nasdaq Minimum Bid Price Requirement
07:00am, Thursday, 01'st Aug 2024
PRINCETON, N.J., Aug. 01, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of deadly conditions in the intensive care unit and cardiac surgery using blood pu
CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website
02:00am, Tuesday, 30'th Jul 2024
PRINCETON, N.J., July 30, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of deadly conditions in the intensive care unit and cardiac surgery using blood pu
CytoSorbents to Present at the Inaugural American Association of Physicians of Indian Origin (AAPI) World Health Congress
07:00am, Wednesday, 17'th Jul 2024
CytoSorbents CEO Dr. Phillip Chan to highlight its innovative critical care and cardiac surgery blood purification therapy at AAPI Conference this weekend
CytoSorbents Secures $20 Million Credit Facility
07:00am, Tuesday, 02'nd Jul 2024
PRINCETON, N.J., July 02, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery usin
CytoSorbents to Host its 2024 Virtual Annual Stockholders Meeting
07:00am, Wednesday, 05'th Jun 2024
PRINCETON, N.J., June 05, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery usin
B. Riley Weighs in on Cytosorbents Co.’s Q2 2024 Earnings (NASDAQ:CTSO)
01:38am, Monday, 20'th May 2024
Cytosorbents Co. (NASDAQ:CTSO – Free Report) – Equities research analysts at B. Riley dropped their Q2 2024 earnings per share estimates for Cytosorbents in a research note issued on Wedne
